Alpha-gal Syndrome, Diagnosis & Management

Diagnosis and management of alpha-gal syndrome (AGS), the lone-star-tick–triggered delayed IgE-mediated allergy to mammalian meat and dairy products. Routes through diagnostic confirmation (delayed reaction pattern + α-Gal sIgE) and cofactor/severity assessment to guide avoidance and emergency action plan intensity.

Evidence tier: Expert consensus. Reflects expert-consensus criteria, not a prospectively validated instrument. Apply clinical judgment and local policy.

Decision points

  • Does the reaction pattern fit alpha-gal syndrome?
  • Has the patient had anaphylaxis, or are cofactors present?

Do-not-miss pitfalls

  • The 2-6 hour delay is the most common reason AGS is missed, reactions are attributed to stress, exercise, or unknown cause when the meal hours earlier is overlooked. Ask specifically about what the patient ate 2-6 hours before the reaction.
  • A negative SPT does not rule out AGS, the alpha-gal epitope is an oligosaccharide (not a protein) and commercial SPT extracts lack adequate alpha-gal content. Serum sIgE is the correct diagnostic test.
  • Cofactors (exercise, alcohol, NSAIDs, fatigue) convert mild reactions into anaphylaxis with the same meal. Counsel specifically, a patient who tolerated a steak once may have anaphylaxis next time if they exercise afterward.
  • Dairy is variably tolerated: some patients react only to red meat; others react to all mammalian products. Start with red meat restriction and assess dairy tolerance separately in mild phenotypes.
  • Alpha-gal IgE is not static, it declines if tick exposure stops and some patients regain tolerance over years (dairy first, then meat). Retest annually; do not assume lifelong restriction without periodic reassessment.
  • The lone star tick (Amblyomma americanum) is the primary sensitizing vector in the US. But other tick species (Ixodes ricinus in Europe, Ixodes holocyclus in Australia) can also sensitize. A patient without US southeastern exposure can still have AGS.
  • Cetuximab (anti-EGFR monoclonal antibody) contains alpha-gal in its Fab region and causes immediate anaphylaxis in AGS patients, alpha-gal sensitization is a contraindication to cetuximab. Always ask about alpha-gal before initiating cetuximab.
  • Gelatin in vaccines and medications also contains alpha-gal and can trigger reactions in highly sensitized patients, consider gelatin-containing injectables as potential triggers if reactions are unexplained.

Evidence & citations

  1. Commins SP, Platts-Mills TAE. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol. 2009;124(4):652-657. PMID 19815111
  2. Platts-Mills TAE, Commins SP, Biedermann T, van Hage M, Levin M, Beck LA, et al. On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Disease Workshop on understanding IgE-mediated mammalian meat allergy. J Allergy Clin Immunol. 2020;145(4):1061-1071. PMID 32057766
  3. Thompson JM, Carpenter A, Kersh GJ, Wachs T, Commins SP, Salzer JS. Geographic distribution of suspected alpha-gal syndrome cases, United States, January 2017–December 2022. MMWR Morb Mortal Wkly Rep. 2023;72(30):815-820. PMID 37498787
  4. Commins SP. Diagnosis & management of alpha-gal syndrome: lessons from 2,500 patients. Expert Rev Clin Immunol. 2020;16(7):667-677. PMID 32571129

Clinician decision support. Verify against the cited source. Not a substitute for clinical judgment. 100% on-device; no patient data is stored or transmitted.